Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items

Taxing choices: Taking the public’s temperature ahead of the budget
The stakes for a government are rarely higher than at a budget. Every chancellor has dealt with this differently. Ken Clarke would draft his budget speech with cigars and whisky, Gordon Brown pored over every word in what officials called…
Great expectations: Rejuvenating the national debate in Scotland
Fresh IPPR Scotland polling shows that politicians must raise their game if next year’s election is a to be serious debate about the challenges facing Scotland and potential solutions.
Unfinished business: Redressing inequality in British policy and Black lives
As conversations about race and equality continue to evolve, Black History Month remains a powerful invitation to pause, reflect, and recommit to progress.